 | • レポートコード：QYR9N8146 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、腫瘍バイオマーカー検査のグローバル市場について調査・分析したレポートで、種類別（前立腺特異抗原検査、CTCテスト、アルファフェトプロテイン（AFP）試験、CAテスト、HER2テスト、その他）、用途別（肺がん、乳がん、結腸直腸、前立腺がん、血液がん）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・腫瘍バイオマーカー検査の世界市場規模 ・主要企業別市場シェア ・腫瘍バイオマーカー検査の世界市場規模：種類別（前立腺特異抗原検査、CTCテスト、アルファフェトプロテイン（AFP）試験、CAテスト、HER2テスト、その他） ・腫瘍バイオマーカー検査の世界市場規模：用途別（肺がん、乳がん、結腸直腸、前立腺がん、血液がん） ・腫瘍バイオマーカー検査のアメリカ市場規模（種類別、用途別） ・腫瘍バイオマーカー検査のヨーロッパ市場規模（種類別、用途別） ・腫瘍バイオマーカー検査の中国市場規模（種類別、用途別） ・腫瘍バイオマーカー検査の日本市場規模（種類別、用途別） ・腫瘍バイオマーカー検査の東南アジア市場規模（種類別、用途別） ・腫瘍バイオマーカー検査のインド市場規模（種類別、用途別） ・腫瘍バイオマーカー検査の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・腫瘍バイオマーカー検査の世界市場予測（2019年-2025年） ・腫瘍バイオマーカー検査の地域別市場予測（2019年-2025年） ... |
In 2018, the global Tumor Biomarker Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Biomarker Test development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
Market segment by Type, the product can be split into
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
Market segment by Application, split into
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players.
To present the Tumor Biomarker Test development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Tumor Biomarker Test are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tumor Biomarker Test Market Size Growth Rate by Type (2014-2025)
1.4.2 Prostate Specific Antigen Tests
1.4.3 CTC Tests
1.4.4 Alpha-Fetoprotein (AFP) Tests
1.4.5 CA Test
1.4.6 HER2 Tests
1.4.7 BRCA Test
1.4.8 Anaplastic Lymphoma Kinase (ALK) Tests
1.4.9 EGFR Mutation Tests
1.4.10 KRAS Test
1.4.11 Others
1.5 Market by Application
1.5.1 Global Tumor Biomarker Test Market Share by Application (2014-2025)
1.5.2 Lung cancer
1.5.3 Breast cancer
1.5.4 Colorectal
1.5.5 Prostate Cancer
1.5.6 Blood Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Tumor Biomarker Test Market Size
2.2 Tumor Biomarker Test Growth Trends by Regions
2.2.1 Tumor Biomarker Test Market Size by Regions (2014-2025)
2.2.2 Tumor Biomarker Test Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Tumor Biomarker Test Market Size by Manufacturers
3.1.1 Global Tumor Biomarker Test Revenue by Manufacturers (2014-2019)
3.1.2 Global Tumor Biomarker Test Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)
3.2 Tumor Biomarker Test Key Players Head office and Area Served
3.3 Key Players Tumor Biomarker Test Product/Solution/Service
3.4 Date of Enter into Tumor Biomarker Test Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Tumor Biomarker Test Market Size by Type (2014-2019)
4.2 Global Tumor Biomarker Test Market Size by Application (2014-2019)
5 United States
5.1 United States Tumor Biomarker Test Market Size (2014-2019)
5.2 Tumor Biomarker Test Key Players in United States
5.3 United States Tumor Biomarker Test Market Size by Type
5.4 United States Tumor Biomarker Test Market Size by Application
6 Europe
6.1 Europe Tumor Biomarker Test Market Size (2014-2019)
6.2 Tumor Biomarker Test Key Players in Europe
6.3 Europe Tumor Biomarker Test Market Size by Type
6.4 Europe Tumor Biomarker Test Market Size by Application
7 China
7.1 China Tumor Biomarker Test Market Size (2014-2019)
7.2 Tumor Biomarker Test Key Players in China
7.3 China Tumor Biomarker Test Market Size by Type
7.4 China Tumor Biomarker Test Market Size by Application
8 Japan
8.1 Japan Tumor Biomarker Test Market Size (2014-2019)
8.2 Tumor Biomarker Test Key Players in Japan
8.3 Japan Tumor Biomarker Test Market Size by Type
8.4 Japan Tumor Biomarker Test Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Tumor Biomarker Test Market Size (2014-2019)
9.2 Tumor Biomarker Test Key Players in Southeast Asia
9.3 Southeast Asia Tumor Biomarker Test Market Size by Type
9.4 Southeast Asia Tumor Biomarker Test Market Size by Application
10 India
10.1 India Tumor Biomarker Test Market Size (2014-2019)
10.2 Tumor Biomarker Test Key Players in India
10.3 India Tumor Biomarker Test Market Size by Type
10.4 India Tumor Biomarker Test Market Size by Application
11 Central & South America
11.1 Central & South America Tumor Biomarker Test Market Size (2014-2019)
11.2 Tumor Biomarker Test Key Players in Central & South America
11.3 Central & South America Tumor Biomarker Test Market Size by Type
11.4 Central & South America Tumor Biomarker Test Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories, Inc.
12.1.1 Abbott Laboratories, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tumor Biomarker Test Introduction
12.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2014-2019)
12.1.5 Abbott Laboratories, Inc. Recent Development
12.2 Agilent Technologies
12.2.1 Agilent Technologies Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tumor Biomarker Test Introduction
12.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2014-2019)
12.2.5 Agilent Technologies Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tumor Biomarker Test Introduction
12.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Becton Dickinson & Co.
12.4.1 Becton Dickinson & Co. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tumor Biomarker Test Introduction
12.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2014-2019)
12.4.5 Becton Dickinson & Co. Recent Development
12.5 Biocept Inc.
12.5.1 Biocept Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tumor Biomarker Test Introduction
12.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2014-2019)
12.5.5 Biocept Inc. Recent Development
12.6 Cancer Genetics Inc.
12.6.1 Cancer Genetics Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tumor Biomarker Test Introduction
12.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2014-2019)
12.6.5 Cancer Genetics Inc. Recent Development
12.7 Danaher Corporation
12.7.1 Danaher Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tumor Biomarker Test Introduction
12.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2014-2019)
12.7.5 Danaher Corporation Recent Development
12.8 Foundation Medicine Inc.
12.8.1 Foundation Medicine Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tumor Biomarker Test Introduction
12.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2014-2019)
12.8.5 Foundation Medicine Inc. Recent Development
12.9 Illumina Inc.
12.9.1 Illumina Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tumor Biomarker Test Introduction
12.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2014-2019)
12.9.5 Illumina Inc. Recent Development
12.10 LabCorp Of America Holdings
12.10.1 LabCorp Of America Holdings Company Details
12.10.2 Company Description and Business Overview
12.10.3 Tumor Biomarker Test Introduction
12.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2014-2019)
12.10.5 LabCorp Of America Holdings Recent Development
12.11 Luminex Corporation
12.12 Myriad Genetics Inc.
12.13 NanoString Technologies Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Tumor Biomarker Test Key Market Segments
Table Key Players Tumor Biomarker Test Covered
Table Global Tumor Biomarker Test Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Tumor Biomarker Test Market Size Market Share by Type 2014-2025
Figure Prostate Specific Antigen Tests Figures
Table Key Players of Prostate Specific Antigen Tests
Figure CTC Tests Figures
Table Key Players of CTC Tests
Figure Alpha-Fetoprotein (AFP) Tests Figures
Table Key Players of Alpha-Fetoprotein (AFP) Tests
Figure CA Test Figures
Table Key Players of CA Test
Figure HER2 Tests Figures
Table Key Players of HER2 Tests
Figure BRCA Test Figures
Table Key Players of BRCA Test
Figure Anaplastic Lymphoma Kinase (ALK) Tests Figures
Table Key Players of Anaplastic Lymphoma Kinase (ALK) Tests
Figure EGFR Mutation Tests Figures
Table Key Players of EGFR Mutation Tests
Figure KRAS Test Figures
Table Key Players of KRAS Test
Figure Others Figures
Table Key Players of Others
Table Global Tumor Biomarker Test Market Size Growth by Application 2014-2025 (Million US$)
Figure Lung cancer Case Studies
Figure Breast cancer Case Studies
Figure Colorectal Case Studies
Figure Prostate Cancer Case Studies
Figure Blood Cancer Case Studies
Figure Tumor Biomarker Test Report Years Considered
Table Global Tumor Biomarker Test Market Size 2014-2025 (Million US$)
Figure Global Tumor Biomarker Test Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tumor Biomarker Test Market Size by Regions 2014-2025 (Million US$)
Table Global Tumor Biomarker Test Market Size by Regions 2014-2019 (Million US$)
Table Global Tumor Biomarker Test Market Share by Regions 2014-2019
Figure Global Tumor Biomarker Test Market Share by Regions 2014-2019
Figure Global Tumor Biomarker Test Market Share by Regions 2019
Table Market Top Trends
Table Global Tumor Biomarker Test Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Tumor Biomarker Test Market Share by Manufacturers (2014-2019)
Figure Global Tumor Biomarker Test Market Share by Manufacturers in 2018
Table Global Tumor Biomarker Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tumor Biomarker Test Product/Solution/Service
Table Date of Enter into Tumor Biomarker Test Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tumor Biomarker Test Market Size by Type (2014-2019) (Million US$)
Table Global Tumor Biomarker Test Market Size Share by Type (2014-2019)
Figure Global Tumor Biomarker Test Market Size Market Share by Type (2014-2019)
Table Global Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table Global Tumor Biomarker Test Market Size Share by Application (2014-2019)
Figure Global Tumor Biomarker Test Market Size Market Share by Application (2014-2019)
Figure Global Tumor Biomarker Test Revenue Market Share by Application in 2018
Figure United States Tumor Biomarker Test Market Size 2014-2019 (Million US$)
Table United States Key Players Tumor Biomarker Test Revenue (2018-2019) (Million US$)
Table United States Key Players Tumor Biomarker Test Market Share (2018-2019)
Table United States Tumor Biomarker Test Market Size by Type (2014-2019) (Million US$)
Table United States Tumor Biomarker Test Market Share by Type (2014-2019)
Table United States Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table United States Tumor Biomarker Test Market Share by Application (2014-2019)
Figure Europe Tumor Biomarker Test Market Size 2014-2019 (Million US$)
Table Europe Key Players Tumor Biomarker Test Revenue (2018-2019) (Million US$)
Table Europe Key Players Tumor Biomarker Test Market Share (2018-2019)
Table Europe Tumor Biomarker Test Market Size by Type (2014-2019) (Million US$)
Table Europe Tumor Biomarker Test Market Share by Type (2014-2019)
Table Europe Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table Europe Tumor Biomarker Test Market Share by Application (2014-2019)
Figure China Tumor Biomarker Test Market Size 2014-2019 (Million US$)
Table China Key Players Tumor Biomarker Test Revenue (2018-2019) (Million US$)
Table China Key Players Tumor Biomarker Test Market Share (2018-2019)
Table China Tumor Biomarker Test Market Size by Type (2014-20189) (Million US$)
Table China Tumor Biomarker Test Market Share by Type (2014-2019)
Table China Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table China Tumor Biomarker Test Market Share by Application (2014-2019)
Figure Japan Tumor Biomarker Test Market Size 2014-2019 (Million US$)
Table Japan Key Players Tumor Biomarker Test Revenue (2018-2019) (Million US$)
Table Japan Key Players Tumor Biomarker Test Market Share (2018-2019)
Table Japan Tumor Biomarker Test Market Size by Type (2014-2019) (Million US$)
Table Japan Tumor Biomarker Test Market Share by Type (2014-2019)
Table Japan Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table Japan Tumor Biomarker Test Market Share by Application (2014-2019)
Figure Southeast Asia Tumor Biomarker Test Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tumor Biomarker Test Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tumor Biomarker Test Market Share (2018-2019)
Table Southeast Asia Tumor Biomarker Test Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Tumor Biomarker Test Market Share by Type (2014-2019)
Table Southeast Asia Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Tumor Biomarker Test Market Share by Application (2014-2019)
Figure India Tumor Biomarker Test Market Size 2014-2019 (Million US$)
Table India Key Players Tumor Biomarker Test Revenue (2018-2019) (Million US$)
Table India Key Players Tumor Biomarker Test Market Share (2018-2019)
Table India Tumor Biomarker Test Market Size by Type (2014-2019) (Million US$)
Table India Tumor Biomarker Test Market Share by Type (2014-2019)
Table India Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table India Tumor Biomarker Test Market Share by Application (2014-2019)
Figure Central & South America Tumor Biomarker Test Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tumor Biomarker Test Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tumor Biomarker Test Market Share (2018-2019)
Table Central & South America Tumor Biomarker Test Market Size by Type (2014-2019) (Million US$)
Table Central & South America Tumor Biomarker Test Market Share by Type (2014-2019)
Table Central & South America Tumor Biomarker Test Market Size by Application (2014-2019) (Million US$)
Table Central & South America Tumor Biomarker Test Market Share by Application (2014-2019)
Table Abbott Laboratories, Inc. Company Details
Table Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2014-2019) (Million US$)
Figure Abbott Laboratories, Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Abbott Laboratories, Inc. Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Agilent Technologies Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table AstraZeneca Recent Development
Table Becton Dickinson & Co. Company Details
Table Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure Becton Dickinson & Co. Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Becton Dickinson & Co. Recent Development
Table Biocept Inc. Company Details
Table Biocept Inc. Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure Biocept Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Biocept Inc. Recent Development
Table Cancer Genetics Inc. Company Details
Table Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure Cancer Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Cancer Genetics Inc. Recent Development
Table Danaher Corporation Company Details
Table Danaher Corporation Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure Danaher Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Danaher Corporation Recent Development
Table Foundation Medicine Inc. Company Details
Table Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure Foundation Medicine Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Foundation Medicine Inc. Recent Development
Table Illumina Inc. Company Details
Table Illumina Inc. Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure Illumina Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table Illumina Inc. Recent Development
Table LabCorp Of America Holdings Company Details
Table LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2014-2019)(Million US$)
Figure LabCorp Of America Holdings Revenue Growth Rate in Tumor Biomarker Test Business (2014-2019)
Table LabCorp Of America Holdings Recent Development
Table Luminex Corporation Company Details
Table Myriad Genetics Inc. Company Details
Table NanoString Technologies Inc. Company Details
Table Global Tumor Biomarker Test Market Size by Regions (Million US$) 2019-2025
Figure Global Tumor Biomarker Test Market Size Share by Regions (2019-2025)
Figure Global Tumor Biomarker Test Market Size Share by Regions in 2025
Figure United States Tumor Biomarker Test Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tumor Biomarker Test Market Size Forecast (2019-2025)(Million USD)
Figure China Tumor Biomarker Test Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tumor Biomarker Test Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tumor Biomarker Test Market Size Forecast (2019-2025)(Million USD)
Figure India Tumor Biomarker Test Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tumor Biomarker Test Market Size Forecast (2019-2025)(Million USD)
Table Global Tumor Biomarker Test Market Size by Product (2019-2025) (Million US$)
Figure Global Tumor Biomarker Test Market Size by Product (2019-2025)
Figure Global Tumor Biomarker Test Market Size by Product in 2025
Table Global Tumor Biomarker Test Market Size by Application (2019-2025) (Million US$)
Figure Global Tumor Biomarker Test Market Size by Application (2019-2025)
Figure Global Tumor Biomarker Test Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の消費者向け関係テスト市場：市場規模・現状・予測 The results of these tests can indicate whether tested individuals are biologically related to one another. For example, kinship testing can establish whether one person is the biological father of another (paternity testing).In 2018, the global Direct-to-consumer Relationship Tests market size was …- 世界の消費者向けDNA関係テスト市場：市場規模・現状・予測 The results of these tests can indicate whether tested individuals are biologically related to one another. For example, kinship testing can establish whether one person is the biological father of another (paternity testing).In 2018, the global Direct-to-consumer Relationship DNA Tests market size …
- 世界の消費者向け遺伝的関係テスト市場：市場規模・現状・予測 The results of these tests can indicate whether tested individuals are biologically related to one another. For example, kinship testing can establish whether one person is the biological father of another (paternity testing).In 2018, the global Direct-to-consumer Relationship Genetic Tests market s…
- 世界の前立腺特異抗原（PSA）検査市場：市場規模・現状・予測 In 2018, the global Prostate-Specific Antigen (PSA) Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Prostate-Specific Antigen (PSA) Test status, future forecast, growth opportunity, key ma…
- 世界のラピッドテスト市場：市場規模・現状・予測 Rapid tests are often referred to as point-of-care tests because rather than sending a blood sample to a laboratory, the test can be conducted and the result read in a doctor’s office or a community setting, without specialised laboratory equipment. The sample taken is usually either finger-prick bl…